A carregar...
Herceptin responsive lung adenocarcinoma in the setting of bilateral synchronous lung primaries and breast carcinoma
The incidence of human epidermal growth factor receptor 2 (Her-2) mutations in lung adenocarcinoma is approximately 3%; however, its significance in the management of these lung cancers remains under investigation. We describe an incidental but unique opportunity to evaluate the response to treatmen...
Na minha lista:
| Publicado no: | Ann Thorac Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Medknow Publications & Media Pvt Ltd
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5264176/ https://ncbi.nlm.nih.gov/pubmed/28197225 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1817-1737.182901 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|